Blood pressure

Angiotensin receptor blockers and the risk of cancer: insights from clinical trials and recent drug recalls

Summarizes clinical trial evidence suggesting a possible link between angiotensin receptor blocker use and cancer, additional clinical evidence tending to refute a link, basic science evidence, and recent information about the problem of potentially cancer-causing impurities found in some angiotensin receptor blocker products.


We review the recent guidelines addressing the diagnosis and management of hypertension.

Strengthening a societal tie and other new initiatives for 2019

Editorial page describing our journal's strengthened ties with the British and Irish Hypertension Society.

Personalized medicine and the treatment of hypertension

Proposes a framework for thinking about pragmatic, one-size-fits-most treatment and highly personalized treatment of hypertension.

Adrenal vein sampling lateralization despite mineralocorticoid receptor antagonists exposure in primary aldosteronism

**Context:** Many antihypertensive medications modulate the renin-angiotensin-aldosterone system, possibly skewing the diagnosis and subtyping of primary aldosteronism (PA). Particularly, mineralocorticoid receptor antagonists (MRA) might raise renin …

Monitoring blood pressure outside of the doctor's office

We explain the approach to out-of-office blood pressure monitoring in 2018.

Out-of-office blood pressure monitoring in 2018

This patient page explains the use of 24-hour ambulatory blood pressure monitoring.

Countries’ geographic latitude and their human populations’ cholesterol and blood pressure

Pharmacologic treatment of hypertension

Use of physician-recommended non-pharmacological strategies for hypertension control among hypertensive patients

This study aims to evaluate the 4 non- pharmacological strategies adopted by patients for hypertension control and patient characteristics that affect the choice of strategies. Four thousand hypertensive patients aged ???18 years were selected from …